Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms [18F]ICF-01006, [18F]MEL-050 |
Target |
Action inhibitors, enhancers |
Mechanism Melanin inhibitors, PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC12H18FN3O |
InChIKeyKDJDPOPMAGYJLH-HSGWXFLFSA-N |
CAS Registry1186533-83-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | France | 24 Aug 2016 |